1-20 of 710 Search Results for

nicotine

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Cancer Epidemiol Biomarkers Prev cebp.0239.2022-3-2 14:14:22.657.
Published: 02 June 2022
... significantly lower concentrations of acrylamide, N, N-dimethylformamide and acrylonitrile. Menthol and nonmenthol smokers presented similar levels of heavy metals. Menthol did not affect the levels of cotinine and the nicotine metabolite ratio in urine. Conclusions: Menthol and nonmenthol cigarettes deliver...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev cebp.0090.2022.
Published: 23 June 2022
...-Trichlorophenol 4,4'-Sulfonyldiphenol Perchlorate Cacodylic acid 3-Hydroxycotinine Dinotefuran 2,5-Dichlorophenol Dichloroacetic acid Cyanuric acid Triclosan Triclocarban Bromodichloromethane Chloroform 3,5,6-Trichloro-2-pyridinol cotinine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol nicotine ammelide...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev cebp.0114.2022.
Published: 22 June 2022
... associated with OC/OPC including tobacco use (created based on the presence of International Classification of Disease, 10th revision (ICD-10) codes Z720 (tobacco use) or F17 (nicotine dependence alcohol use, and diagnosis of HIV/Acquired Immune Deficiency Syndrome (HIV/AIDS). Odds ratios and 95% Wald...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2022) 31 (6): 1233–1242.
Published: 01 June 2022
... for the influence of other confounders ( 38 ). We chose 378 SNPs significantly associated with smoking initiation (i.e., ever smoked regularly) in the GWAS & Sequencing Consortium of Alcohol and Nicotine use consortium and 77 with BMI in the Genetic Investigation of ANthropometric Traits consortium ( 39, 40...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2022) 31 (5): 1058–1067.
Published: 04 May 2022
... , Zhang Y , Wei J , Sun Y , . MicroRNA124-IL6R mediates the effect of nicotine in inflammatory bowel disease by shifting Th1/Th2 balance toward Th1 . Front Immunol 2020 ; 11 : 235 . 22. Tejero JD , Armand NC , Finn CM , Dhume K , Strutt TM...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2022) 31 (4): 758–765.
Published: 01 April 2022
..., lung, colorectal and ovarian cancer screening trial models and validation . J Natl Cancer Inst 2011 ; 103 : 1058 – 68 . 12. Wilcox RG , Hughes J , Roland J . Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2022) 31 (1_Supplement): PO-273.
Published: 01 January 2022
...-being.Racial and ethnic minorities are adversely targeted by tobacco industry resulting in high tobacco use and tobacco related disease burden. With increased retailing of both tobacco and electronic nicotine delivery systems (ENDS) products, cancer centers such as City of Hope are prioritizing tobacco...
Journal Articles
Cancer Epidemiol Biomarkers Prev (2022) 31 (1_Supplement): PO-204.
Published: 01 January 2022
...-2017). During 21.5 years of follow-up, we documented 8,696 PCa cases and 1,171 deaths from PCa. Smoking status, pack years, and age at initiation were obtained at baseline. Total nicotine equivalents (TNE) for smokers were imputed by an algorithm developed based on a subset of participants (n=2,239...
Journal Articles
Cancer Epidemiol Biomarkers Prev (2022) 31 (1): 269–279.
Published: 11 January 2022
... T. Heated tobacco products (HTP) are a novel type of tobacco products that allow the inhalation of aerosols containing nicotine and various chemicals produced by electrically heated tobacco leaves ( 1, 2 ). HTPs such as Ploom by JT ( 3 ), IQOS by Philip Morris International ( 4 ), and glo...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2022) 31 (1): 230–235.
Published: 11 January 2022
... cirrhosis, drug use disorder except nicotine/caffeine, hemochromatosis, Budd-Chiari syndrome, viral hepatitis, unspecified chronic hepatitis, or Wilson's disease (see ICD codes in Supplementary Table S2). These inclusion and exclusion criteria were based on the recent consensus statement by an expert panel...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2022) 31 (1): 5–10.
Published: 11 January 2022
... .  The effect of smoking cues in antismoking advertisements on smoking urge and psychophysiological reactions . Nicotine Tob Res   2009 ; 11 : 254 – 61 . 50. Petticrew   M , Maani Hessari   N , Knai   C , Weiderpass   E .  How alcohol industry organisations mislead the public about alcohol...
Journal Articles
Cancer Epidemiol Biomarkers Prev (2021) 30 (12): 2268–2277.
Published: 03 December 2021
... as covariates. HRs, including individuals with and without imputed BMI, were then compared to assure that the inferences did not change due to the imputed BMI. Tobacco smoking was identified with the ICD-9 code for “tobacco use disorders” 305.1, ICD-10 codes for nicotine dependence, and with CPT codes...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2021) 30 (10): 1956–1964.
Published: 01 October 2021
... ( 24 ). The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), however, found that among 4,071 U.S. adults diagnosed with past-year nicotine dependence at baseline (2001–2002), a lifetime history of cannabis use was not associated with continued nicotine dependence [based on DSM...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2021) 30 (10): 1947–1955.
Published: 01 October 2021
... In 2018, 8.1 million U.S. adults (3.2%) were current electronic nicotine delivery systems (ENDS) or e-cigarette users ( 1 ). Based upon a recent systematic review, the most common reason for using e-cigarettes is to quit (77.4%) or reduce (85.6%) cigarette smoking; evidence is suggestive...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2021) 30 (9): 1681–1688.
Published: 01 September 2021
... : e1004518 . 34. Singh   S , Pillai   S , Chellappan   S .  Nicotinic acetylcholine receptor signaling in tumor growth and metastasis . J Oncol   2011 ; 2011 : 456743 . 35. Felix   AS , Yang   HP , Gierach   GL , Park   Y , Brinton   LA .  Cigarette smoking...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2021) 30 (10): 1965–1973.
Published: 01 October 2021
... ; 42 : 206 – 9 . 39. Fluharty   M , Taylor   AE , Grabski   M , Munafò   MR .  The association of cigarette smoking with depression and anxiety: a systematic review . Nicotine Tob Res   2017 ; 19 : 3 – 13 . 40. Wynder   EL , Higgins   IT , Harris   RE .  The wish bias...
Includes: Supplementary data
Journal Articles
Cancer Epidemiol Biomarkers Prev (2021) 30 (8): 1462–1471.
Published: 01 August 2021
... could plausibly be explained by interference with signaling through the estrogen receptor α. However, this is unlikely to explain the lower risks of thyroid and clear cell ovarian cancers. For thyroid cancer, an anti-inflammatory effect of nicotine and reduced TSH levels from smoking have been proposed...
Journal Articles
Cancer Epidemiol Biomarkers Prev (2021) 30 (7): 1450.
Published: 01 July 2021
..., and quit effort. While adjusting for cigarettes per day (CPD) may be an interesting analysis, it may not provide an accurate description of exposure. That is why we purposely did not adjust for CPD. Despite higher versus lower ventilated cigarettes having lower machine-determined tar/nicotine yields...
Journal Articles
Cancer Epidemiol Biomarkers Prev (2020) 29 (10): 1968–1972.
Published: 01 October 2020
...Brian L. Rostron; Blair Coleman; Yu-Ching Cheng; Heather L. Kimmel; Olusola Oniyide; Lanqing Wang; Cindy M. Chang Background: Previous studies have examined the characteristics of open and closed system electronic nicotine delivery system (ENDS) users, but population-level information on nicotine...
Includes: Supplementary data
Images
Receipt of medical doctor advice to quit and use of effective cessation tre...
Published: 01 July 2021
Figure 2. Receipt of medical doctor advice to quit and use of effective cessation treatments, by race/ethnicity, US adults ≥18 years, TUS-CPS 2018–2019. aWas advised by a medical doctor to stop smoking among those who saw a medical doctor during the past year and were current smokers or former smokers who quit in the past year. bUnstable estimates [suppressed for American Indian/Alaska Native (AI/AN), Asian persons]. cUsed one-on-one in-person counseling; and/or a stop-smoking clinic, class, or support group; and/or a telephone helpline or quit line among current smokers who tried to quit during the past year or used when they stopped smoking among former smokers who quit during the past 2 years. dUsed a nicotine patch, gum, lozenge, nasal spray or inhaler; and/or a prescription pill called Chantix, Varenicline, Zyban, Bupropion, or Wellbutrin during the past year among current smokers who tried to quit during the past year or used when they stopped smoking among former smokers who quit during the past 2 years. Note: Estimates are survey weighted. Estimates for White, Black, AI/AN, Asian persons are among non-Hispanics. Estimate for Asian persons does not include Native Hawaiians or other Pacific Islander persons. Figure 2. Receipt of medical doctor advice to quit and use of effective cessation treatments, by race/ethnicity, US adults ≥18 years, TUS-CPS 2018–2019. aWas advised by a medical doctor to stop smoking among those who saw a medical doctor during the past year and were current smokers or former smokers who quit in the past year. bUnstable estimates [suppressed for American Indian/Alaska Native (AI/AN), Asian persons]. cUsed one-on-one in-person counseling; and/or a stop-smoking clinic, class, or support group; and/or a telephone helpline or quit line among current smokers who tried to quit during the past year or used when they stopped smoking among former smokers who quit during the past 2 years. dUsed a nicotine patch, gum, lozenge, nasal spray or inhaler; and/or a prescription pill called Chantix, Varenicline, Zyban, Bupropion, or Wellbutrin during the past year among current smokers who tried to quit during the past year or used when they stopped smoking among former smokers who quit during the past 2 years. Note: Estimates are survey weighted. Estimates for White, Black, AI/AN, Asian persons are among non-Hispanics. Estimate for Asian persons does not include Native Hawaiians or other Pacific Islander persons. More